Bone Biologics (BBLGW) Return on Invested Capital (2016 - 2017)
Bone Biologics (BBLGW) has disclosed Return on Invested Capital for 2 consecutive years, with 1.69% as the latest value for Q3 2017.
Bone Biologics (BBLGW) has disclosed Return on Invested Capital for 2 consecutive years, with 1.69% as the latest value for Q3 2017.